237 related articles for article (PubMed ID: 20599871)
1. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
Taylor PJ; Tai CH; Franklin ME; Pillans PI
Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
[TBL] [Abstract][Full Text] [Related]
2. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
Yang Z; Wang S
J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS for immunosuppressant therapeutic drug monitoring.
Sallustio BC
Bioanalysis; 2010 Jun; 2(6):1141-53. PubMed ID: 21083213
[TBL] [Abstract][Full Text] [Related]
4. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
5. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
Meinitzer A; Gartner G; Pilz S; Stettin M
Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
[TBL] [Abstract][Full Text] [Related]
6. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
7. Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.
Koster RA; Alffenaar JW; Greijdanus B; Uges DR
Talanta; 2013 Oct; 115():47-54. PubMed ID: 24054560
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of immunosuppressants by liquid chromatography-mass spectrometry.
McShane AJ; Bunch DR; Wang S
Clin Chim Acta; 2016 Feb; 454():1-5. PubMed ID: 26721314
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry.
Koal T; Deters M; Casetta B; Kaever V
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):215-22. PubMed ID: 15135093
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.
Sadilkova K; Busby B; Dickerson JA; Rutledge JC; Jack RM
Clin Chim Acta; 2013 Jun; 421():152-6. PubMed ID: 23473895
[TBL] [Abstract][Full Text] [Related]
12. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
[TBL] [Abstract][Full Text] [Related]
13. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants.
Ceglarek U; Casetta B; Lembcke J; Baumann S; Fiedler GM; Thiery J
Clin Chim Acta; 2006 Nov; 373(1-2):168-71. PubMed ID: 16806142
[TBL] [Abstract][Full Text] [Related]
14. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients.
Laverdière I; Caron P; Couture F; Lévesque E; Guillemette C
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():131-7. PubMed ID: 22265668
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
16. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
17. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
Deprez S; Van Uytfanghe K; Stove CP
Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
[TBL] [Abstract][Full Text] [Related]
19. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.
Koster RA; Veenhof H; Botma R; Hoekstra AT; Berger SP; Bakker SJ; Alffenaar JC; Touw DJ
Bioanalysis; 2017 Apr; 9(7):553-563. PubMed ID: 28300419
[TBL] [Abstract][Full Text] [Related]
20. Internal standard selection for immunosuppressant drugs measured by high-performance liquid chromatography tandem mass spectrometry.
Taylor PJ
Ther Drug Monit; 2007 Feb; 29(1):131-2. PubMed ID: 17304163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
